Work

A phase I and pharmacokinetic study of docetaxel combined with Doxil (pegylated liposomal doxorubicin) without and with granulocyte colony stimulating factor

Year: 2004

Type: article

Study design: Clinical Trial

Source: Anti-Cancer Drugs

DOI: 10.1097/00001813-200402000-00004

Authors: Anna C. Pavlick, Catherine Chodkiewicz, Leonard Liebes, Anne Hamilton, Carolyn Wasserheit, Howard Hochster, James Speyer, Zo?? Phillips, Andrea Downey, Joan Sorich, Franco Muggia

Institutions: NYU Langone Health, New York University

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Center for Research Resources

Awards: General Clinical Research Center, G5953508653, G9000242378, Cancer Center Support Grant

OpenAlex ID: W2005735799

FWCI: 0.95

Cites:

Cited by: 12

Related to: 10